|
Monday February 4, 2008
Hathaway (HWYI) Enters Into LOI With Korean
Medical Device Manufacturer, U & I Bio-Tech, Inc.
Revolutionary Non-Invasive Medical Diagnostic Device Holds
Huge Marketing Potential
SAINT PETERSBURG, FL--(MARKET WIRE)--Feb 4, 2008 -- Hathaway Corporation
(Other OTC:HWYI.PK - News), a company that focuses on acquiring,
developing, and managing disruptive technologies in the telecommunications,
medical devices, and software fields that change the way companies
grow and service their businesses globally, announced that the Company
has entered into a Letter of Intent for a joint venture with U&I
Bio-Tech, Inc., a South Korea-based Medical Device Company, for
BioHarp, a unique diagnostic medical device currently in development
by U&I. BioHarp's revolutionary patented technology will provide
physicians with the capability to diagnose a variety of ailments
quickly, accurately, and in a totally safe and non-invasive manner.
"We are very excited about adding the BioHarp product line,
with its massive worldwide marketing potential, to Hathaway's group
of companies. A medical device that can assist physicians in diagnosing
physical ailments non-invasively is truly remarkable and further
illustrates our commitment to finding disruptive technologies. Our
experience in this area makes this project a great fit. We are also
particularly looking forward to working with the impressive team
at U&I Bio-Tech," stated Mr. Paul D. Lisenby, CEO of Hathaway.
"We have already commenced our due diligence, which will include
exploring different market segments for BioHarp, as well as regulatory
clearance in various countries, such as the FDA in the US. Once
all our parameters are met, we plan to close the deal in 45-60 days."
About Hathaway
Hathaway Global Inc. focuses on acquiring disruptive technologies
in the telecommunications, medical devices, and software fields
that can change or alter the way companies grow and service their
businesses globally. Hathaway provides financial and infrastructural
support to create revenue growth companies, positioning them to
leverage the opportunities such technologies are typically capable
of. Hathaway then offers the company on the public market or facilitates
a buyout. Through companies like OptiCon, Hathaway brings the communication
solutions of the future to today's business marketplace. To request
further information about Hathaway, please email us at investors@hathawayglobal.com
Forward-Looking Statements
This press release may contain forward-looking statements covered
within the meaning of the Private Securities Litigation Reform Act
of 1995. These forward-looking statements relate to, among other
things, plans and timing for the introduction or enhancement of
our services and products, statements about future market conditions,
supply and demand conditions, and other expectations, intentions
and plans contained in this press release that are not historical
fact and involve risks and uncertainties. Our expectations regarding
future revenues depend upon our ability to develop and supply products
and services that we may not produce today and that meet defined
specifications. When used in this press release, the words "plan,"
"expect," "believe," and similar expressions
generally identify forward-looking statements. These statements
reflect our current expectations. They are subject to a number of
risks and uncertainties, including, but not limited to, changes
in technology and changes in pervasive markets.
Contact:
FutureTechIR for Hathaway Corporation
Investor Relations
(817) 812-2105
|
